Trials / Unknown
UnknownNCT06072417
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
Comparative Study of Sleep Disordered Breathing (SDB) in Patients With Pulmonary Vascular Diseases Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 2840m vs. at Low Altitude (LA) Sea Level
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To study the effect of relocation from 2840m (Quito) to sea level (Pedernales) in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live \>2500m on sleep disordered breathing
Detailed description
This research in patients with PVD diagnosed with precapillary PH with right heart catheterization and classified to groups 1 and 4 (PAH or CTEPH) who permanently live at HA \>2500 (PVDHA) will have nocturnal respiratory sleep studies near their living altitude in Quito at 2840m and at sea level in Pedernales during the first and the second night after relocation.
Conditions
- Pulmonary Vascular Disease
- Pulmonary Artery Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Assessment without intervention at High altitude | Assessments at High altitude corresponding to Baseline measures |
| OTHER | Relocation to sea level for 2 days | Participants will be relocated to sea level and intervention and have assessements there. |
Timeline
- Start date
- 2023-09-22
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2023-10-10
- Last updated
- 2023-10-10
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06072417. Inclusion in this directory is not an endorsement.